found that pharmacologic inhibition of STING reduces infarction size and scarring, restoring ventricular systolic function to near-normal levels three weeks post-reperfusion in MI mice, with a noted decrease in myocardial hypertrophy (44). This evidence concerns the gene STING1 and cardiac hypertrophy.